How we got here
From launching in June 2020 to our planned open consultation in July 2021, GCTC's journey is detailed below..
The GCTC launched to produce reliable and proportionate Guidance for RCTs in all health interventions.
Jan - Mar 2021
Guidance development of the first draft. Quicksand, a design-thinking and innovation practice based in India, began consultations with RCT teams and participants in India, South Africa, Nigeria, Thailand, Brazil, Sierra Leone and Kenya to gather insights from diverse RCT types and settings.
Final draft published for open consultation
October - November 2021
Review of consultation responses and redrafting guidance
The Collaborative published revised draft guidance
June -July 2020
We ran a global survey to hear from researchers whose trials had been impacted by the Covid-19 pandemic to capture the innovative practices that have enabled some trials to continue and the challenges that have affected others.
Further consultation with multidisciplinary stakeholders and programme of participant/public focused workshops.
Produced the report on Conducting Clinical Trials During a Pandemic: Reviewing the resilience of the ecosystem for Randomized Controlled Trials (RCTs). This report was based on the global survey of researchers experiences, we ran in 2020.
Workshops with multidisciplinary writing group of global experts scrutinised Collaborative's response to consultation feedback
Sep -Dec 2020
We consulted our Steering Group and over 80 experts through a series of workshops focusing on the writing process and Guidance document content.
May -June 2021
Guidance development of the second draft. Quicksand completed its consultations and produced a report with findings and recommendations for the guidance.
August - September 2021
Launch of public consultation
Translation of draft guidance into Arabic, simplified Chinese, Japanese, Spanish, French